Abbott Laboratories (BMV:ABT)
2,427.34
0.00 (0.00%)
At close: Oct 9, 2025
Abbott Laboratories Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 6,951 | 7,616 | 6,896 | 9,882 | 9,799 | 6,838 | Upgrade |
Short-Term Investments | 331 | 351 | 383 | 288 | 450 | 310 | Upgrade |
Cash & Short-Term Investments | 7,282 | 7,967 | 7,279 | 10,170 | 10,249 | 7,148 | Upgrade |
Cash Growth | 0.87% | 9.45% | -28.43% | -0.77% | 43.38% | 72.66% | Upgrade |
Accounts Receivable | 7,972 | 6,925 | 6,565 | 6,218 | 6,487 | 6,414 | Upgrade |
Inventory | 6,954 | 6,194 | 6,570 | 6,173 | 5,157 | 5,012 | Upgrade |
Other Current Assets | 2,260 | 2,570 | 2,256 | 2,663 | 2,346 | 1,867 | Upgrade |
Total Current Assets | 24,468 | 23,656 | 22,670 | 25,224 | 24,239 | 20,441 | Upgrade |
Net Property, Plant & Equipment | 11,395 | 10,658 | 10,154 | 9,162 | 8,959 | 9,029 | Upgrade |
Other Intangible Assets | 5,920 | 6,647 | 8,815 | 10,454 | 12,739 | 14,784 | Upgrade |
Goodwill | 23,952 | 23,108 | 23,679 | 22,799 | 23,231 | 23,744 | Upgrade |
Long-Term Investments | 958 | 886 | 799 | 766 | 816 | 821 | Upgrade |
Other Long-Term Assets | 17,306 | 16,459 | 7,097 | 6,033 | 5,212 | 3,729 | Upgrade |
Total Assets | 83,999 | 81,414 | 73,214 | 74,438 | 75,196 | 72,548 | Upgrade |
Accounts Payable | 4,306 | 4,195 | 4,295 | 4,607 | 4,408 | 3,946 | Upgrade |
Accrued Expenses | 7,206 | 6,844 | 7,019 | 7,401 | 6,806 | 6,581 | Upgrade |
Short-Term Debt | - | - | - | - | - | 213 | Upgrade |
Current Portion of Long-Term Debt | 507 | 1,500 | 1,080 | 2,251 | 754 | 7 | Upgrade |
Other Current Liabilities | 1,420 | 1,618 | 1,447 | 1,230 | 1,137 | 1,160 | Upgrade |
Total Current Liabilities | 13,439 | 14,157 | 13,841 | 15,489 | 13,105 | 11,907 | Upgrade |
Long-Term Debt | 12,930 | 12,625 | 13,599 | 14,522 | 17,296 | 18,527 | Upgrade |
Other Long-Term Liabilities | 6,801 | 6,731 | 6,947 | 7,522 | 8,771 | 9,111 | Upgrade |
Total Long-Term Liabilities | 19,731 | 19,356 | 20,546 | 22,044 | 26,067 | 27,638 | Upgrade |
Total Liabilities | 33,170 | 33,513 | 34,387 | 37,533 | 39,172 | 39,545 | Upgrade |
Common Stock | 25,284 | 25,153 | 24,869 | 24,709 | 24,470 | 24,145 | Upgrade |
Treasury Stock | -16,610 | -16,844 | -15,981 | -15,229 | -11,822 | -10,042 | Upgrade |
Accumulated Other Comprehensive Income | -6,576 | -7,906 | -7,839 | -8,051 | -8,374 | -8,946 | Upgrade |
Retained Earnings | 48,467 | 47,261 | 37,554 | 35,257 | 31,528 | 27,627 | Upgrade |
Total Common Shareholders' Equity | 50,565 | 47,664 | 38,603 | 36,686 | 35,802 | 32,784 | Upgrade |
Minority Interest | 264 | 237 | 224 | 219 | 222 | 219 | Upgrade |
Shareholders' Equity | 50,829 | 47,901 | 38,827 | 36,905 | 36,024 | 33,003 | Upgrade |
Total Liabilities & Equity | 83,999 | 81,414 | 73,214 | 74,438 | 75,196 | 72,548 | Upgrade |
Total Debt | 13,437 | 14,125 | 14,679 | 16,773 | 18,050 | 18,747 | Upgrade |
Net Cash (Debt) | -6,155 | -6,158 | -7,400 | -6,603 | -7,801 | -11,599 | Upgrade |
Net Cash Per Share | -3.52 | -3.52 | -4.23 | -3.74 | -4.36 | -6.49 | Upgrade |
Book Value | 50,565 | 47,664 | 38,603 | 36,686 | 35,802 | 32,784 | Upgrade |
Book Value Per Share | 28.94 | 27.27 | 22.07 | 20.80 | 20.01 | 18.36 | Upgrade |
Tangible Book Value | 20,693 | 17,909 | 6,109 | 3,433 | -168 | -5,744 | Upgrade |
Tangible Book Value Per Share | 11.84 | 10.25 | 3.49 | 1.95 | -0.09 | -3.22 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.